Clay E. Comstock, Ph.D.
Affiliations: | 2003 | The University of North Dakota, Grand Forks, ND, United States | |
| 2018- | Salish Kootenai College, Pablo, MT, United States |
Area:
Biochemistry, Molecular BiologyWebsite:
https://www.researchgate.net/profile/Clay_ComstockGoogle:
"Clay Comstock"Mean distance: 12.39 | S | N | B | C | P |
Parents
Sign in to add mentor| John B. Shabb | grad student | 2003 | University of North Dakota | |
| (The role of phosphorylation on the stability of the type Ialpha regulatory subunit of cAMP -dependent protein kinase.) | ||||
| Karen E. Knudsen | post-doc | 2003-2007 | (Cell Biology Tree) | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang AY, Chiam K, Haupt Y, et al. (2018) An Analysis of a Multiple Biomarker Panel to Better Predict Prostate Cancer Metastasis After Radical Prostatectomy. International Journal of Cancer |
| McNair C, Urbanucci A, Comstock CE, et al. (2016) Cell cycle-coupled expansion of AR activity promotes cancer progression. Oncogene |
| Londin E, Loher P, Telonis AG, et al. (2015) Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proceedings of the National Academy of Sciences of the United States of America. 112: E1106-15 |
| McNair C, Goodwin J, Augello M, et al. (2015) Abstract 1844: Genome wide analysis of AR-cell cycle interplay reveals novel functions in cancer Cancer Research. 75: 1844-1844 |
| Comstock CE, Knudsen KE. (2013) IGF2 revs the steroidogenesis engine. Endocrine-Related Cancer. 20: C19-21 |
| Comstock CE, Augello MA, Goodwin JF, et al. (2013) Targeting cell cycle and hormone receptor pathways in cancer. Oncogene. 32: 5481-91 |
| Balasubramaniam S, Comstock CE, Ertel A, et al. (2013) Aberrant BAF57 signaling facilitates prometastatic phenotypes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2657-67 |
| Comstock CE, Augello MA, Schiewer MJ, et al. (2011) Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function. The Journal of Biological Chemistry. 286: 8117-27 |
| Sharma A, Yeow WS, Ertel A, et al. (2010) The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. The Journal of Clinical Investigation. 120: 4478-92 |
| Olshavsky NA, Comstock CE, Schiewer MJ, et al. (2010) Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene. Cancer Research. 70: 3975-84 |